According to a new report North America Biosurgery Market, published by KBV Research, the North America Biosurgery Market would witness market growth of 6.4% CAGR during the forecast period (2019-2025).
The US market dominated the North America Neurological Surgeries Market by Country in 2018, and would continue to be a dominant market till 2025. The Canada market is anticipated to witness a CAGR of 9.2% during (2019 - 2025). Additionally, The Mexico market would witness a CAGR of 9.3% during (2019 - 2025).
The Surgical sealants market dominated the Canada Biosurgery Market by Product in 2018, thereby, achieving a market value of $351.9 million by 2025. The Soft Tissue Attachments market is expected to witness a CAGR of 9.4% during (2019 - 2025). The Bone Graft Substitutes market is experiencing a CAGR of 9.3% during (2019 - 2025). Additionally, The Adhesion Barriers market is poised to witness significant growth rate of 8.9% during (2019 - 2025).
The General Surgeries market dominated the Mexico Biosurgery Market by Application in 2018, growing at a CAGR of 7.3 % during the forecast period. The Orthopedic Surgeries market is expected to witness a CAGR of 7.5% during (2019 - 2025). Additionally, The Neurological Surgeries market is estimated to witness highest CAGR of 9.3% during (2019 - 2025).
Report Structural Insights: https://www.kbvresearch.com/north-america-biosurgery-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.
By Application
By Product
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
